Table 4

HIV prevalence among women attending colposcopy services

Authors, publication yearPublication typeGeographical locationStudy periodParticipants (n)Overall HIV prevalence
(measured) %)
Overall prevalence of HIV infection
(patient-reported and measured) (%)
Prevalence of new HIV infections
(among women accepting testing) (%)
CD4+ <200/mm3 on HIV diagnosis (%)No or low-grade dysplasia* on HIV diagnosis (%)
Testing in any grade of cervical dysplasia (no dysplasia, LSIL, HSIL)
Maiman et al, 198840LetterNew York, USA19886610.6
Dottino et al, 199139AbstractNew York, USA19911166NANA
Spitzer et al, 199341ArticleNew York, USA1990–199120811.46.168.8
Jennings et al, 199642ArticleNew York, USA1990–199419083.311.874.3
Creighton et al, 201243LetterLondon, UK2010–20116872.20.190100
Testing in patients with HSIL
Rosenvinge et al, 201144AbstractLondon, UK20118291.70NANA
Mosimann et al, 201445ArticleLausanne, Switzerland2002–2012581.70
  • Articles are listed in chronological order of publication.

  • Created by the authors.

  • *Cervical intraepithelial neoplasia stage 1 or LSIL.

  • HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NA, not applicable.